The discovery of biomarkers such as phospho-tau217 marked an important advancement in Alzheimer’s diagnosis. This particular ...

The consumables segment accounted for the largest share by product & service segment in the biomarkers market in 2023. By product & service, the biomarkers market is categorized into consumables, ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

In recent years, scientists have worked hard to find better ways to detect dementia, including Alzheimer's disease, long ...

Genentech announced that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s ...

Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and daily ...

Roche presented new data at the AD/PD 2025 International Conference demonstrating that trontinemab, in its Phase Ib/IIa Brainshuttle™ AD study, ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® ...